Dexcom, Inc. 8-K Report: Key Insights from May 1, 2025 Filing

$DXCM
Form 8-K
Filed on: 2025-05-01
Source
Dexcom, Inc. 8-K Report: Key Insights from May 1, 2025 Filing

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Dexcom, Inc.
  • State of Incorporation: Delaware (DE)
  • SEC Central Index Key (CIK): 0001093557
  • SEC File Number: 000-51222
  • IRS Employer Identification Number (EIN): 33-0857544
  • Address: 6340 Sequence Drive, San Diego, CA 92121
  • Phone Number: 858-200-0200
  1. Filing Information:
  • Filing Type: 8-K (current report)
  • Filing Date: May 1, 2025
  1. Stock Information:
  • Type of Stock: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: DXCM
  • Exchange: NASDAQ
  1. Period of Report:
  • Report Start Date: May 1, 2025
  • Report End Date: May 1, 2025
  • The report covers a single day.
  1. XBRL and XML Information:
  • The report is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for financial reporting.

Summary:

This report is a Form 8-K filed by Dexcom, Inc. on May 1, 2025. It provides essential details about the company's identity, its stock, and the nature of the filing. No significant financial data or performance metrics are included in this section. The filing indicates that Dexcom is compliant with SEC reporting requirements and is traded on the NASDAQ under the ticker DXCM.